nodes	percent_of_prediction	percent_of_DWPC	metapath
Ridogrel—TBXAS1—hip joint—osteoporosis	0.395	0.599	CbGeAlD
Ridogrel—TBXAS1—hip—osteoporosis	0.244	0.37	CbGeAlD
Ridogrel—TBXAS1—Prostaglandin Synthesis and Regulation—ANXA2—osteoporosis	0.0315	0.0925	CbGpPWpGaD
Ridogrel—TBXA2R—Small Ligand GPCRs—CNR2—osteoporosis	0.0259	0.076	CbGpPWpGaD
Ridogrel—TBXAS1—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.0158	0.0465	CbGpPWpGaD
Ridogrel—TBXAS1—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.0128	0.0377	CbGpPWpGaD
Ridogrel—TBXAS1—uterus—osteoporosis	0.0112	0.0171	CbGeAlD
Ridogrel—TBXAS1—bone marrow—osteoporosis	0.00955	0.0145	CbGeAlD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—WDR1—osteoporosis	0.00898	0.0264	CbGpPWpGaD
Ridogrel—TBXAS1—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.00831	0.0244	CbGpPWpGaD
Ridogrel—TBXAS1—Arachidonic acid metabolism—GPX1—osteoporosis	0.00783	0.023	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—CAP1—osteoporosis	0.0071	0.0208	CbGpPWpGaD
Ridogrel—TBXAS1—Biological oxidations—CYP27A1—osteoporosis	0.00681	0.02	CbGpPWpGaD
Ridogrel—TBXAS1—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.00673	0.0198	CbGpPWpGaD
Ridogrel—TBXA2R—G alpha (q) signalling events—MGLL—osteoporosis	0.00644	0.0189	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—MGLL—osteoporosis	0.00576	0.0169	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—MGLL—osteoporosis	0.00564	0.0166	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—PLEK—osteoporosis	0.00516	0.0151	CbGpPWpGaD
Ridogrel—TBXAS1—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.00499	0.0147	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—WDR1—osteoporosis	0.00463	0.0136	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.00455	0.0134	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—TLN1—osteoporosis	0.00444	0.0131	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—VCL—osteoporosis	0.00438	0.0129	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.00432	0.0127	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—CALCR—osteoporosis	0.00409	0.012	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—PTH1R—osteoporosis	0.00409	0.012	CbGpPWpGaD
Ridogrel—TBXAS1—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.00405	0.0119	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—RAP1A—osteoporosis	0.00366	0.0108	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—CAP1—osteoporosis	0.00366	0.0107	CbGpPWpGaD
Ridogrel—TBXAS1—Biological oxidations—CYP19A1—osteoporosis	0.00358	0.0105	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.00336	0.00986	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—FGA—osteoporosis	0.00332	0.00976	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.00327	0.00961	CbGpPWpGaD
Ridogrel—TBXA2R—GPCRs, Class A Rhodopsin-like—CNR2—osteoporosis	0.00321	0.00943	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—FGB—osteoporosis	0.00302	0.00888	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—MGLL—osteoporosis	0.00291	0.00854	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	0.00275	0.00808	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—PLEK—osteoporosis	0.00266	0.00781	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—ANXA2—osteoporosis	0.00266	0.00781	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.00261	0.00768	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—CALCR—osteoporosis	0.00231	0.00679	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—PTH1R—osteoporosis	0.00231	0.00679	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—TLN1—osteoporosis	0.00229	0.00673	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—VCL—osteoporosis	0.00226	0.00664	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.00222	0.00653	CbGpPWpGaD
Ridogrel—TBXAS1—Biological oxidations—POMC—osteoporosis	0.00215	0.00632	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—PTH—osteoporosis	0.00215	0.00631	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—CALCR—osteoporosis	0.0021	0.00617	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—PTH1R—osteoporosis	0.0021	0.00617	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—CNR2—osteoporosis	0.00209	0.00615	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—FDPS—osteoporosis	0.00203	0.00596	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—PKM—osteoporosis	0.00203	0.00596	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—WNT1—osteoporosis	0.00197	0.00578	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—GPD2—osteoporosis	0.00192	0.00565	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—PGLS—osteoporosis	0.00192	0.00565	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—RAP1A—osteoporosis	0.00189	0.00555	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—MGLL—osteoporosis	0.00184	0.00539	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—PTHLH—osteoporosis	0.00178	0.00523	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—ATIC—osteoporosis	0.00176	0.00516	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—PNP—osteoporosis	0.00176	0.00516	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—FGA—osteoporosis	0.00171	0.00503	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—MGLL—osteoporosis	0.00167	0.0049	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—CALCA—osteoporosis	0.00157	0.0046	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—FGB—osteoporosis	0.00156	0.00458	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—OXCT1—osteoporosis	0.00149	0.00439	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—CA2—osteoporosis	0.00149	0.00439	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—MGLL—osteoporosis	0.00146	0.00428	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	0.00142	0.00417	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	0.00137	0.00404	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—SOST—osteoporosis	0.00137	0.00403	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—IGF1—osteoporosis	0.00137	0.00402	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PTH1R—osteoporosis	0.00124	0.00364	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CALCR—osteoporosis	0.00124	0.00364	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—IDH2—osteoporosis	0.00124	0.00364	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—PTH—osteoporosis	0.00121	0.00357	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—CNR2—osteoporosis	0.00118	0.00348	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—CYP27A1—osteoporosis	0.00116	0.00342	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—ACP5—osteoporosis	0.00113	0.00333	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	0.00112	0.00329	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—PTH—osteoporosis	0.0011	0.00324	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.00108	0.00316	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—CNR2—osteoporosis	0.00107	0.00316	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—TPI1—osteoporosis	0.00105	0.00309	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—WNT1—osteoporosis	0.00101	0.00297	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—PTHLH—osteoporosis	0.00101	0.00296	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—P4HB—osteoporosis	0.00099	0.00291	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—MGLL—osteoporosis	0.000985	0.00289	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—GAPDH—osteoporosis	0.000972	0.00286	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—LRP5—osteoporosis	0.000961	0.00282	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—RAP1A—osteoporosis	0.000947	0.00278	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—LRP6—osteoporosis	0.00092	0.0027	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—PTHLH—osteoporosis	0.000914	0.00268	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—CALCA—osteoporosis	0.000886	0.0026	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	0.000825	0.00243	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	0.00082	0.00241	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—POMC—osteoporosis	0.00082	0.00241	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—CALCA—osteoporosis	0.000804	0.00236	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—TLN1—osteoporosis	0.000776	0.00228	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—ENO1—osteoporosis	0.000765	0.00225	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—PSMA2—osteoporosis	0.000754	0.00222	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—PSMA5—osteoporosis	0.000754	0.00222	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—IGF1—osteoporosis	0.000705	0.00207	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—P4HB—osteoporosis	0.00067	0.00197	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PTH—osteoporosis	0.000651	0.00191	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—RAP1A—osteoporosis	0.00064	0.00188	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CNR2—osteoporosis	0.000635	0.00186	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	0.000632	0.00186	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—ADCY5—osteoporosis	0.00063	0.00185	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—NFATC1—osteoporosis	0.000624	0.00183	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—DKK1—osteoporosis	0.00062	0.00182	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—CYP19A1—osteoporosis	0.000612	0.0018	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—WNT1—osteoporosis	0.000597	0.00175	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—FGA—osteoporosis	0.000581	0.00171	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—ADCY5—osteoporosis	0.000572	0.00168	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PTHLH—osteoporosis	0.00054	0.00159	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—BMP2—osteoporosis	0.00054	0.00159	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—FGB—osteoporosis	0.000528	0.00155	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PSMA5—osteoporosis	0.00051	0.0015	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PSMA2—osteoporosis	0.00051	0.0015	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—ADCY5—osteoporosis	0.0005	0.00147	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—GPX1—osteoporosis	0.000498	0.00146	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CALCA—osteoporosis	0.000475	0.0014	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—POMC—osteoporosis	0.000463	0.00136	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—MTHFR—osteoporosis	0.00046	0.00135	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—KL—osteoporosis	0.000431	0.00127	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—TGFB1—osteoporosis	0.000423	0.00124	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—POMC—osteoporosis	0.000421	0.00124	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—IL6R—osteoporosis	0.000411	0.00121	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—POMC—osteoporosis	0.000368	0.00108	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—ADCY5—osteoporosis	0.000338	0.000993	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—SPP1—osteoporosis	0.000327	0.000961	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—IRS2—osteoporosis	0.000296	0.000869	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—LEP—osteoporosis	0.000289	0.00085	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—ESR1—osteoporosis	0.000276	0.000812	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—IRS1—osteoporosis	0.000258	0.000758	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—POMC—osteoporosis	0.000249	0.00073	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—IL6R—osteoporosis	0.000242	0.000713	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—IGF1—osteoporosis	0.000239	0.000703	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—IL6—osteoporosis	0.000183	0.000537	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—MYC—osteoporosis	0.000144	0.000422	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—TGFB1—osteoporosis	0.000143	0.000421	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—IL6—osteoporosis	0.000108	0.000317	CbGpPWpGaD
